The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Pediatric Rheumatology Learning at the 2019 ACR/ARP Annual Meeting

Pediatric Rheumatology Learning at the 2019 ACR/ARP Annual Meeting

October 18, 2019 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF

At this year’s ACR/ARP Annual Meeting, Nov. 8–13, all of the pediatric rheumatology sessions will take place in the same room, making it easy to access all of the exciting content. Planners hope this convenient setup facilitates networking before and after symposia.

You Might Also Like
  • Pediatric Rheumatology on Point: Explore Breakthroughs & Networking Opportunities at the 2019 ACR/ARP Annual Meeting
  • Sit Back & Enjoy Learning at the 2019 ACR/ARP Annual Meeting
  • Innovative Education Formats & More: What’s New at the 2019 ACR/ARP Annual Meeting
Explore This Issue
October 2019
Also By This Author
  • Undercoding Is Not an Audit-Proof Strategy in Medical Documentation

“In pediatric rheumatology, we are very tight-knit community. This [event] is our opportunity to meet with each other, and the format will help us do our networking around our symposia,” says Anne M. Stevens, MD, PhD, a professor in the Department of Pediatrics, University of Washington, Seattle, and the Annual Meeting Planning Committee Pediatrics Subcommittee chair for 2019.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

New: Pediatric Community Lounge

For the first time, the pediatric rheumatology community will have a dedicated hub at the ACR/ARP Annual Meeting. In the new lounge, pediatric attendees can hang out in comfortable seating areas, network with colleagues, watch live-streamed scientific sessions and grab a quick snack. Attendees will have plenty of opportunity to grab a coffee and chat with colleagues, or even launch new research collaborations.

Sessions with Broad Appeal

Dr. Stevens and her subcommittee have planned pediatric sessions that will appeal to a wide audience. “These are diseases adult rheuma­tologists see as well, and they are often extremely severe diseases,” she says. “Pediatric rheumatologists may see them more often, but everyone will be interested in the new data coming out on these conditions.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

High participation from international pediatric rheumatologists is expected, so session content will reflect this globally diverse audience.

“In pediatric rheumatology, our diseases are so rare,” Dr. Stevens says. “I am involved in scleroderma research. And there are only one in three million—or about 270 pediatric patients—in the U.S. who have systemic sclerosis. So it’s a challenge to conduct this research and better understand the disease. It’s helpful to interact with colleagues at the Annual Meeting. Together, we can identify a cohort of patients and find out who may be interested in collaborating on trials. We are currently collaborating with a group in Turkey, for example. These accidental meetings at the Annual Meeting are so important. And this is an opportunity to increase that ‘accidental’ meeting rate.”

Exciting pediatrics sessions planned for the 2019 Annual Meeting include:

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Therapeutic Approaches to Macrophage Activation Syndrome
Monday, Nov. 11, 8:30–10 a.m.
Quick diagnosis and treatment initiation for macrophage activation syndrome (MAS) can save children’s lives. This session’s speakers will each lead groundbreaking clinical trials in IL-6, IL-18 and IL-23 treatments.

“MAS is not as rare as we once thought. It could be seen in autoimmune diseases, such as systemic onset juvenile arthritis or lupus, or in such settings as infection,” says Dr. Stevens. “When rheumatologists see MAS, they know how to recognize and treat it—and you can turn this [disease] around with the right treatment. We’ll have the top three experts at this session, and the focus is the role of treatment selection.”

Juvenile Localized Scleroderma: Does This Child Have Active Disease?
Tuesday, Nov. 12, 11 a.m.–12 p.m.
Dermatologists may refer patients with juvenile localized scleroderma, which can cause deep scarring, to rheumatologists. “The disease is very invasive, and can begin on the leg and then go into the brain,” Dr. Stevens says. “It’s a very slow disease, and it’s challenging to know if there is active scarring or if it’s more quiet. Do these patients need more immunosuppression or less?”

During the session, these important clinical questions, as well as the most recent data on ultrasound and thermography, will be discussed by experts in the field.

Pages: 1 2 | Single Page

Filed Under: Education & Training, From the College Tagged With: 2019 ACR/ARP Annual Meeting, Pediatric RheumatologyIssue: October 2019

You Might Also Like:
  • Pediatric Rheumatology on Point: Explore Breakthroughs & Networking Opportunities at the 2019 ACR/ARP Annual Meeting
  • Sit Back & Enjoy Learning at the 2019 ACR/ARP Annual Meeting
  • Innovative Education Formats & More: What’s New at the 2019 ACR/ARP Annual Meeting
  • Rheumatology Education Reboot: Fresh, Interactive Session Formats at the 2019 ACR/ARP Annual Meeting

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)